Skip to Content Facebook Feature Image

Adnan Syed's murder conviction still stands as he seeks sentence reduction in 'Serial' case

News

Adnan Syed's murder conviction still stands as he seeks sentence reduction in 'Serial' case
News

News

Adnan Syed's murder conviction still stands as he seeks sentence reduction in 'Serial' case

2025-02-26 20:41 Last Updated At:20:50

BALTIMORE (AP) — Despite documented problems with the evidence against him and an earlier request from prosecutors to clear his record, Adnan Syed will remain convicted of murder, according to court papers filed Tuesday night.

The decision from Baltimore prosecutors comes ahead of a scheduled hearing Wednesday morning where a judge will consider whether to reduce Syed’s sentence, but this means the conviction itself is no longer in question.

It’s the latest wrinkle in an ongoing legal odyssey that garnered a massive following after being featured in the “Serial” podcast over a decade ago.

Syed’s attorneys recently filed the request for a sentence reduction under Maryland’s Juvenile Restoration Act, a relatively new state law that provides a potential pathway to release for people serving long prison terms for crimes committed when they were minors. That request is supported by prosecutors.

Meanwhile, Baltimore State’s Attorney Ivan Bates announced Tuesday that his office is withdrawing a previously filed motion to vacate Syed’s conviction in the 1999 killing of his high school ex-girlfriend, Hae Min Lee, who was found strangled to death and buried in a makeshift grave.

“I did not make this decision lightly, but it is necessary to preserve the credibility of our office and maintain public trust in the justice system,” Bates said in a statement.

Syed’s attorney Erica Suter issued a statement late Tuesday, criticizing the move and reasserting Syed’s innocence.

“Tonight, the state’s attorney got it wrong,” Suter said. “His decision to withdraw his office’s motion to vacate Adnan’s conviction ignores the injustices on which this conviction was founded. We will continue to fight to clear his name through all legal avenues available to him.”

The original motion to vacate — which was filed by Bates’ predecessor Marilyn Mosby — won Syed his freedom in 2022. But his conviction was reinstated following a procedural challenge from Lee’s family. The Maryland Supreme Court ordered a redo of the conviction vacatur hearing after finding that the family didn’t receive adequate notice to attend in person.

Since the prosecutor’s office changed hands in the meantime, the decision of whether to withdraw the motion fell to Bates.

Instead of asking a judge to again consider Syed’s guilt or innocence, Bates chose a different path. He supported Syed’s motion for a reduced sentence — without addressing the underlying conviction.

Bates said that since his release in 2022, Syed has demonstrated he is a productive member of society whose continued freedom is “in the interest of justice.” He said the case “is precisely what legislators envisioned when they crafted the Juvenile Restoration Act.”

The legislation was passed amid growing consensus that such defendants are especially open to rehabilitation, partly because brain science shows cognitive development continues well beyond the teenage years. Syed was 17 when Lee was killed.

Now 43, he has been working at Georgetown University’s Prisons and Justice Initiative and caring for aging relatives since his release, according to court filings. His father died in October after a long illness.

Bates was facing a Friday deadline to decide on the motion to vacate.

After reviewing the motion filed by his predecessor, Bates concluded that it contained “false and misleading statements that undermine the integrity of the judicial process,” he said in a statement Tuesday.

Bates wrote in an executive summary released Tuesday that his decision “does not preclude Mr. Syed from raising any new issues that he believes will support his innocence in the proper post-trial pleadings.”

“However, properly shifting this burden back to Mr. Syed will re-instill the adversarial nature of proceedings that are the hallmark of the truth-seeking function of our criminal justice system,” the summary says.

Attorneys for the victim’s family had argued that prosecutors should address the integrity of Syed’s conviction before the court considered reducing his sentence. Prosecutors “should not be allowed to duck the issue by hiding behind” his motion for a reduced sentence, attorneys wrote in a recent filing.

Syed has maintained his innocence from the beginning, but many questions remain unanswered even after the “Serial” podcast combed through the evidence, reexamined legal arguments and interviewed witnesses. The series debuted in 2014 and drew millions of listeners who became armchair detectives.

Rife with legal twists and turns, the case has recently pitted criminal justice reform efforts against the rights of crime victims and their families, whose voices are often at odds with a growing movement to acknowledge and correct systemic racism, police misconduct and prosecutorial missteps.

When prosecutors sought to vacate Syed’s conviction in 2022, they cited numerous problems with the case, including alternative suspects and unreliable evidence presented at trial. A judge agreed to vacate the conviction and free Syed. Prosecutors in Mosby’s office later chose not to refile charges after they said DNA testing excluded Syed as a suspect.

Even though the appellate courts reinstated his conviction, they allowed Syed to remain free while the case continued.

FILE - Adnan Syed, right, and his mother Shamim Rahman, follow attorney Erica Sutter, not in the photo, to talk with reporters outside Maryland's Supreme Court in Annapolis, Md., Oct. 5, 2023, following arguments in an appeal by Syed, whose conviction for killing his ex-girlfriend more than 20 years ago was chronicled in the hit podcast "Serial." (AP Photo/Susan Walsh, File)

FILE - Adnan Syed, right, and his mother Shamim Rahman, follow attorney Erica Sutter, not in the photo, to talk with reporters outside Maryland's Supreme Court in Annapolis, Md., Oct. 5, 2023, following arguments in an appeal by Syed, whose conviction for killing his ex-girlfriend more than 20 years ago was chronicled in the hit podcast "Serial." (AP Photo/Susan Walsh, File)

SAN FRANCISCO & JACKSONVILLE, Fla.--(BUSINESS WIRE)--Jan 12, 2026--

Abridge, the leading enterprise-grade AI for clinical conversations, is collaborating with Availity, the nation’s largest real-time health information network, to launch a first-of-its kind prior authorization experience. The engagement uses cutting-edge technology grounded in the clinician-patient conversation to facilitate a more efficient process between clinicians and health plans in medical necessity review.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112960386/en/

Rather than creating parallel AI systems across healthcare stakeholders, Abridge and Availity are working together to ensure shared clinical context at the point of conversation powers administrative processes, such as prior authorization review and submission, improving outcomes for patients and the teams delivering care.

This collaboration unites two trusted and scaled organizations: combining Abridge’s enterprise-grade AI platform, serving over 200 health systems and projected to support over 80 million patient-clinician conversations in 2026, with Availity’s next-generation, FHIR-native Intelligent Utilization Management solution, which helps payers and providers digitize and operationalize coverage requirements within administrative workflows.

Availity’s FHIR-native APIs enable fast, scalable, and secure connectivity of payer information across the entire healthcare ecosystem. With Abridge’s Contextual Reasoning Engine technology, clinicians can gain visibility into relevant clinical information during the conversation to support documentation aligned with prior authorization requirements.

“At Availity, we’ve invested in building AI-powered, FHIR-native APIs designed to bring clinical policy logic directly into provider workflows,” said Russ Thomas, CEO of Availity. “By embedding our technology at the point of conversation, we’re enabling faster, more transparent utilization management decisions rooted in clinical context. We’re excited to collaborate with Abridge and to demonstrate what’s possible when payer intelligence meets real-time provider workflows.”

The development of real-time prior authorization is just a component of a broader revenue cycle collaboration that is focused on applying real-time conversational intelligence across the patient, provider, and payer experiences. The companies intend to support integration by collaborating on workflow alignment between their respective platforms in the following areas:

“Abridge and Availity are each bringing national scale, deep trust, and a track record of solving important challenges across the care and claims experience to this partnership,” said Dr. Shiv Rao, CEO and Co-Founder of Abridge. “We’re building real-time bridges between patients, providers, and payers, unlocking shared understanding, focused at the point of conversation.”

About Availity

Availity empowers payers and providers to deliver transformative patient experiences by enabling the seamless exchange of clinical, administrative, and financial information. As the nation's largest real-time health information network, Availity develops intelligent, automated, and interoperable solutions that foster collaboration and shared value across the healthcare ecosystem. With connections to over 95% of payers, more than 3 million providers, and over 2,000 trading partners, Availity provides mission-critical connectivity to drive the future of healthcare innovation. For more information, including an online demonstration, please visit www.availity.com or call 1.800.AVAILITY (282.4548). Follow us on LinkedIn.

About Abridge

Abridge was founded in 2018 to power deeper understanding in healthcare. Abridge is now trusted by more than 200 of the largest and most complex health systems in the U.S. The enterprise-grade AI platform transforms medical conversations into clinically useful and billable documentation at the point of care, reducing administrative burden and clinician burnout while improving patient experience. With deep EHR integration, support for 28+ languages, and 50+ specialties, Abridge is used across a wide range of care settings, including outpatient, emergency department, and inpatient.

Abridge’s enterprise-grade AI platform is purpose-built for healthcare. Supported by Linked Evidence, Abridge is the only solution that maps AI-generated summaries to source data, helping clinicians quickly trust and verify the output. As a pioneer in generative AI for healthcare, Abridge is setting the industry standard for the responsible deployment of AI across health systems.

Abridge was awarded Best in KLAS 2025 for Ambient AI in addition to other accolades, including Forbes 2025 AI 50 List, TIME Best Inventions of 2024, and Fortune’s 2024 AI 50 Innovators.

Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation

Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation

Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation

Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation

Recommended Articles